Nutritional Supplements in Psychiatric Disorders Industry Trends & Competitive Analysis 2033

Nutritional Supplements in Psychiatric Disorders by Type (Omega-3 Fatty Acids, Amino Acids, Vitamins, Herbal Supplements, Others, World Nutritional Supplements in Psychiatric Disorders Production), by Application (Clinical Practice, Research and Development, Personalized Medicine, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 135

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 135

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Key Insights

The market for nutritional supplements in psychiatric disorders is experiencing robust growth, driven by increasing awareness of mental health issues, a rising prevalence of psychiatric disorders globally, and a growing preference for complementary and alternative medicine approaches. The market's value, estimated at $8 billion in 2025, is projected to exhibit a compound annual growth rate (CAGR) of 7% from 2025 to 2033, reaching approximately $14 billion by 2033. This growth is fueled by several key trends, including the increasing integration of nutritional supplements into conventional psychiatric treatment plans, the development of specialized formulations targeting specific mental health conditions (such as anxiety, depression, and ADHD), and the expanding research base demonstrating the efficacy of certain nutrients in supporting mental well-being. Leading companies such as Now Foods, Nature's Bounty, and Garden of Life are actively contributing to market expansion through product innovation, strategic partnerships, and robust marketing efforts. However, the market also faces certain restraints, including regulatory challenges related to supplement efficacy claims, concerns regarding potential drug interactions, and the need for rigorous clinical evidence supporting the benefits of specific supplements. Market segmentation is primarily based on supplement type (e.g., omega-3 fatty acids, vitamins B, probiotics), target condition, and distribution channel (e.g., online retailers, pharmacies).

Geographic distribution reveals significant regional variations. North America currently dominates the market, owing to high healthcare expenditure, advanced healthcare infrastructure, and significant consumer awareness of mental health and wellness. Europe follows as a substantial market, while Asia-Pacific is anticipated to witness rapid growth in the coming years due to rising disposable incomes, increasing mental health awareness, and growing adoption of integrative healthcare practices. The competitive landscape is characterized by both large multinational corporations and smaller specialized companies, fostering innovation and offering consumers a diverse range of products. Future growth opportunities will stem from the development of personalized supplement formulations, expansion into emerging markets, and continued research into the interaction between nutrition and mental health. The emphasis on personalized approaches, backed by scientific evidence, will be crucial in shaping future market dynamics.

Nutritional Supplements in Psychiatric Disorders Research Report - Market Size, Growth & Forecast

Nutritional Supplements in Psychiatric Disorders Trends

The market for nutritional supplements in psychiatric disorders is experiencing significant growth, driven by a confluence of factors including the rising prevalence of mental health issues, increasing awareness of the role of nutrition in mental well-being, and a growing preference for complementary and alternative medicine (CAM) therapies. The global market, estimated at $XXX million in 2025, is projected to reach $XXX million by 2033, exhibiting a robust CAGR during the forecast period (2025-2033). This expansion is fueled by several key trends. Firstly, a substantial increase in the diagnosis of conditions like anxiety, depression, and attention-deficit/hyperactivity disorder (ADHD) is creating a larger pool of potential consumers seeking effective treatment options. Secondly, growing scientific evidence highlighting the connection between nutritional deficiencies and mental health is leading to greater acceptance of supplements as adjunctive therapies. Omega-3 fatty acids, for instance, are increasingly recognized for their potential benefits in mood regulation. Thirdly, a shift towards personalized medicine is driving demand for specialized formulations catering to individual needs and specific psychiatric conditions. This trend is reflected in the emergence of targeted supplements designed to address particular symptoms or neurotransmitter imbalances. The historical period (2019-2024) witnessed a steady growth trajectory, laying the groundwork for the projected exponential expansion during the forecast period. The year 2025 serves as both the base year and estimated year for our analysis. This period is characterized by increased regulatory scrutiny, a rise in direct-to-consumer marketing, and an evolving understanding of the efficacy of various supplements in managing psychiatric disorders. Furthermore, increasing integration of nutritional supplements into conventional psychiatric care is expected to propel market growth in the coming years. The industry is witnessing a convergence of traditional medicine and complementary approaches, creating opportunities for collaborative ventures and increased market penetration. Finally, the development of innovative supplement delivery systems, such as targeted delivery mechanisms and advanced formulations, is driving further market expansion.

Driving Forces: What's Propelling the Nutritional Supplements in Psychiatric Disorders Market?

Several key forces are driving the growth of the nutritional supplements market within the context of psychiatric disorders. The escalating global prevalence of mental health issues, particularly anxiety and depression, constitutes a primary driver. Millions of individuals worldwide suffer from these conditions, creating a substantial demand for effective treatment options. Furthermore, growing dissatisfaction with conventional treatments, including concerns about side effects and limited efficacy in certain cases, is prompting patients to explore alternative and complementary therapies, including nutritional supplements. The increasing awareness among both healthcare professionals and the general public regarding the crucial role of nutrition in mental health is also a significant factor. Research continues to uncover the intricate relationship between diet, nutritional deficiencies, and mental well-being, further legitimizing the use of targeted supplements. This heightened awareness is translated into increased consumer demand and adoption. Moreover, the rising popularity of functional foods and beverages enriched with nutrients known to benefit mental health is indirectly driving the market. Consumers are increasingly seeking proactive measures to improve their mental well-being, contributing to the overall expansion of the market. The evolving regulatory landscape, while posing some challenges, also provides opportunities for market growth through increased transparency and quality control. As regulations become more stringent, consumer confidence in the efficacy and safety of supplements is likely to increase.

Nutritional Supplements in Psychiatric Disorders Growth

Challenges and Restraints in Nutritional Supplements in Psychiatric Disorders

Despite the promising growth outlook, the nutritional supplements market for psychiatric disorders faces several challenges. A primary concern is the lack of robust scientific evidence supporting the efficacy of many supplements. While some supplements, such as omega-3 fatty acids, show promise, many others lack rigorous clinical trials to confirm their effectiveness in treating specific psychiatric conditions. This lack of evidence creates uncertainty among both healthcare professionals and consumers, hindering broader adoption. Regulatory inconsistencies across different countries also pose a significant challenge. Varying regulations regarding the production, labeling, and marketing of supplements can create obstacles to market entry and expansion. Ensuring consistent quality and safety standards across international markets is crucial for establishing consumer trust. Furthermore, the significant price difference between various brands and formulations can act as a barrier for certain consumer groups, particularly those with limited financial resources. The cost of high-quality, clinically tested supplements can make them inaccessible to a large segment of the population, potentially limiting market penetration. Finally, the prevalence of misleading marketing claims and unsubstantiated testimonials creates a significant challenge in ensuring consumer safety and informed decision-making. Combating misinformation and promoting evidence-based information is crucial for maintaining the integrity of the market and promoting responsible consumption.

Key Region or Country & Segment to Dominate the Market

The North American market is projected to hold a significant share of the global market due to high awareness of mental health issues, relatively high disposable incomes, and increased access to healthcare services. Within this region, the United States is anticipated to exhibit the strongest growth due to its large population and high prevalence of mental health disorders. Europe, particularly Western European countries, is another key market due to its robust healthcare infrastructure and growing adoption of complementary therapies. Asia-Pacific is expected to witness significant growth in the coming years, driven by factors such as rising disposable incomes, increasing awareness of mental health, and a growing preference for natural health solutions. However, challenges such as regulatory hurdles and varying levels of awareness across the region could influence market penetration.

North America (USA & Canada): High per capita healthcare spending, advanced healthcare infrastructure, and substantial prevalence of mental health issues drive substantial demand.

Europe (Western Europe): Increased acceptance of alternative therapies and a well-established healthcare system fuel significant market growth.

Asia Pacific (Japan, China, India, Australia): Rising disposable incomes, a growing middle class, and increasing awareness of mental health issues are major contributing factors.

Segment Dominance: Omega-3 fatty acids and other supplements targeting neurotransmitter imbalances, such as those involving serotonin and dopamine, are anticipated to represent significant market segments. Additionally, specialized formulations addressing specific conditions like anxiety, depression, and ADHD are expected to experience strong growth. The market is segmented by supplement type (e.g., omega-3 fatty acids, vitamins, minerals, herbal extracts), by application (e.g., anxiety, depression, ADHD, bipolar disorder), and by distribution channel (e.g., online retailers, pharmacies, health food stores). The high demand for tailored solutions is expected to significantly contribute to market growth, as more specialized products are developed.

Growth Catalysts in Nutritional Supplements in Psychiatric Disorders Industry

The convergence of increasing awareness of the gut-brain axis, personalized medicine approaches tailored to individual needs, and the continued evolution of research into the neurobiological effects of various nutrients are significant catalysts for growth within this industry. These factors are collectively driving both innovation and consumer demand for effective and targeted solutions. The expansion of telemedicine also offers new opportunities for reaching broader patient populations and providing personalized guidance regarding supplement usage.

Leading Players in the Nutritional Supplements in Psychiatric Disorders Market

Now Foods

Nature’s Bounty

Garden of Life

Nordic Naturals

Jarrow Formulas

Thorne Research

Pure Encapsulations

Integrative Therapeutics

Life Extension

Metagenics

Significant Developments in Nutritional Supplements in Psychiatric Disorders Sector

2020: Increased focus on research into the role of the gut microbiome in mental health.

2021: Several key publications highlight the potential benefits of specific nutrients in managing anxiety and depression.

2022: Launch of several new supplement formulations targeting specific neurotransmitter pathways.

2023: Increased regulatory scrutiny of marketing claims related to mental health supplements.

2024: Growth of personalized nutrition programs integrating supplements into treatment plans.

Comprehensive Coverage Nutritional Supplements in Psychiatric Disorders Report

This report offers a detailed analysis of the nutritional supplements market within the context of psychiatric disorders, providing valuable insights into market trends, drivers, challenges, and key players. The comprehensive coverage includes in-depth market sizing and forecasting, regional breakdowns, segment analysis, and competitive landscape assessments, empowering stakeholders with a clear understanding of the market dynamics and opportunities for growth.

Nutritional Supplements in Psychiatric Disorders Segmentation

1.Type1.1. Omega-3 Fatty Acids1.2. Amino Acids1.3. Vitamins1.4. Herbal Supplements1.5. Others1.6. World Nutritional Supplements in Psychiatric Disorders Production

1.1. Omega-3 Fatty Acids

1.2. Amino Acids

1.3. Vitamins

1.4. Herbal Supplements

1.5. Others

1.6. World Nutritional Supplements in Psychiatric Disorders Production

2.Application2.1. Clinical Practice2.2. Research and Development2.3. Personalized Medicine2.4. Other

2.1. Clinical Practice

2.2. Research and Development

2.3. Personalized Medicine

2.4. Other

Nutritional Supplements in Psychiatric Disorders Segmentation By Geography

1.North America1.1. United States1.2. Canada1.3. Mexico

1.1. United States

1.2. Canada

1.3. Mexico

2.South America2.1. Brazil2.2. Argentina2.3. Rest of South America

2.1. Brazil

2.2. Argentina

2.3. Rest of South America

3.Europe3.1. United Kingdom3.2. Germany3.3. France3.4. Italy3.5. Spain3.6. Russia3.7. Benelux3.8. Nordics3.9. Rest of Europe

3.1. United Kingdom

3.2. Germany

3.3. France

3.4. Italy

3.5. Spain

3.6. Russia

3.7. Benelux

3.8. Nordics

3.9. Rest of Europe

4.Middle East & Africa4.1. Turkey4.2. Israel4.3. GCC4.4. North Africa4.5. South Africa4.6. Rest of Middle East & Africa

4.1. Turkey

4.2. Israel

4.3. GCC

4.4. North Africa

4.5. South Africa

4.6. Rest of Middle East & Africa

5.Asia Pacific5.1. China5.2. India5.3. Japan5.4. South Korea5.5. ASEAN5.6. Oceania5.7. Rest of Asia Pacific

5.1. China

5.2. India

5.3. Japan

5.4. South Korea

5.5. ASEAN

5.6. Oceania

5.7. Rest of Asia Pacific

Nutritional Supplements in Psychiatric Disorders Regional Share

Market Growth (million)

Regional Market Share

Market Size (million)

Market Snapshot

Loading chart…

12 items

1. Executive Summary

2. Nutritional Supplements in Psychiatric Disorders Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Nutritional Supplements in Psychiatric Disorders Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Nutritional Supplements in Psychiatric Disorders Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Nutritional Supplements in Psychiatric Disorders Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Nutritional Supplements in Psychiatric Disorders Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Nutritional Supplements in Psychiatric Disorders Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Nutritional Supplements in Psychiatric Disorders Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Nutritional Supplements in Psychiatric Disorders Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Nutritional Supplements in Psychiatric Disorders Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Nutritional Supplements in Psychiatric Disorders Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Nutritional Supplements in Psychiatric Disorders Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Nutritional Supplements in Psychiatric Disorders Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Nutritional Supplements in Psychiatric Disorders Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Nutritional Supplements in Psychiatric Disorders Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Nutritional Supplements in Psychiatric Disorders Market Competition by Key Manufacturers

9.1. Global Nutritional Supplements in Psychiatric Disorders Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Nutritional Supplements in Psychiatric Disorders: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Now Foods

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Nature’s Bounty

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Garden of Life

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Nordic Naturals

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Jarrow Formulas

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Thorne Research

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Pure Encapsulations

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Integrative Therapeutics

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Life Extension

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Metagenics

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Nutritional Supplements in Psychiatric Disorders Market

Figure 4: Global Nutritional Supplements in Psychiatric Disorders Market: Drivers

Figure 5: Global Nutritional Supplements in Psychiatric Disorders Market: Challenges

Figure 6: Global Nutritional Supplements in Psychiatric Disorders Market: Trends

Figure 7: Global Nutritional Supplements in Psychiatric Disorders Market: Opportunity

Figure 8: Global Nutritional Supplements in Psychiatric Disorders Market: Restraint

Figure 9: Global Nutritional Supplements in Psychiatric Disorders Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Nutritional Supplements in Psychiatric Disorders Market Value (USD Million) By Region

Figure 19: Global Nutritional Supplements in Psychiatric Disorders Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Nutritional Supplements in Psychiatric Disorders Market Value (USD Million) By Region

Figure 27: Global Nutritional Supplements in Psychiatric Disorders Market Share (%) By: Regions (2032)

Figure 28: Global Nutritional Supplements in Psychiatric Disorders Market Volume (K) By Region

Figure 29: Global Nutritional Supplements in Psychiatric Disorders Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Nutritional Supplements in Psychiatric Disorders Market Value (USD Million) By Region

Figure 37: Global Nutritional Supplements in Psychiatric Disorders Market Share (%) By: Regions (2032)

Figure 38: Global Nutritional Supplements in Psychiatric Disorders Market Volume (K) By Region

Figure 39: Global Nutritional Supplements in Psychiatric Disorders Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Nutritional Supplements in Psychiatric Disorders Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Nutritional Supplements in Psychiatric Disorders Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Nutritional Supplements in Psychiatric Disorders Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Nutritional Supplements in Psychiatric Disorders Market Value (USD Million) By Region

Table 14: Global Nutritional Supplements in Psychiatric Disorders Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Nutritional Supplements in Psychiatric Disorders Market Volume (K) By Region

Table 31: Global Nutritional Supplements in Psychiatric Disorders Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Nutritional Supplements in Psychiatric Disorders Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Nutritional Supplements in Psychiatric Disorders Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Nutritional Supplements in Psychiatric Disorders Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Now Foods Basic Information And Sales Area

Table 52: Now Foods. Products Portfolio

Table 53: Nature’s Bounty Basic Information And Sales Area

Table 54: Nature’s Bounty. Products Portfolio

Table 55: Garden of Life Basic Information And Sales Area

Table 56: Garden of Life. Products Portfolio

Table 57: Nordic Naturals Basic Information And Sales Area

Table 58: Nordic Naturals. Products Portfolio

Table 59: Jarrow Formulas Basic Information And Sales Area

Table 60: Jarrow Formulas. Products Portfolio

Table 61: Thorne Research Basic Information And Sales Area

Table 62: Thorne Research. Products Portfolio

Table 63: Pure Encapsulations Basic Information And Sales Area

Table 64: Pure Encapsulations. Products Portfolio

Table 65: Integrative Therapeutics Basic Information And Sales Area

Table 66: Integrative Therapeutics. Products Portfolio

Table 67: Life Extension Basic Information And Sales Area

Table 68: Life Extension. Products Portfolio

Table 69: Metagenics Basic Information And Sales Area

Table 70: Metagenics. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Type

Table 72: Global Market Share (%) By Type (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Volume (K) (2025-2032) By Type

Table 76: Global Market Share (%) By Type (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Nutritional Supplements in Psychiatric Disorders Market Value (USD Million) By Region

Table 80: Global Nutritional Supplements in Psychiatric Disorders Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Type

Table 83: North America Market Value (USD Million) (2025-2032) By Application

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Type

Table 86: Europe Market Value (USD Million) (2025-2032) By Application

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Type

Table 92: South America Market Value (USD Million) (2025-2032) By Application

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 96: Global Nutritional Supplements in Psychiatric Disorders Market Volume (K) By Region

Table 97: Global Nutritional Supplements in Psychiatric Disorders Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Type

Table 100: North America Market Volume (K) (2025-2032) By Application

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Type

Table 103: Europe Market Volume (K) (2025-2032) By Application

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Type

Table 109: South America Market Volume (K) (2025-2032) By Application

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

FAQs

1. What is the projected Compound Annual Growth Rate (CAGR) of the Nutritional Supplements in Psychiatric Disorders?

The projected CAGR is approximately 7.8.

2. Which companies are prominent players in the Nutritional Supplements in Psychiatric Disorders?

Key companies in the market include Now Foods, Nature’s Bounty, Garden of Life, Nordic Naturals, Jarrow Formulas, Thorne Research, Pure Encapsulations, Integrative Therapeutics, Life Extension, Metagenics.

3. What are the main segments of the Nutritional Supplements in Psychiatric Disorders?

The market segments include Type, Application.

4. Can you provide details about the market size?

The market size is estimated to be 1200

5. What are some drivers contributing to market growth?

Increasing Demand for Various Applications to Aid Market Growth.

6. What are the notable trends driving market growth?

Increasing Demand for Various Applications to Aid Market Growth.

7. Are there any restraints impacting market growth?

Increasing Demand for Various Applications to Aid Market Growth.

8. Can you provide examples of recent developments in the market?

2020: Increased focus on research into the role of the gut microbiome in mental health.

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4480.00, USD 6720.00, and USD 8960.00 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in 1200.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "Nutritional Supplements in Psychiatric Disorders," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the Nutritional Supplements in Psychiatric Disorders report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided with the report for further details.

14. How can I stay updated on further developments or reports in the Nutritional Supplements in Psychiatric Disorders?

To stay informed about further developments, trends, and reports in the Nutritional Supplements in Psychiatric Disorders, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Contact for Full Report

Loading report content...

Nutritional Supplements in Psychiatric Disorders Industry Trends & Competitive Analysis 2033

Key Insights

Nutritional Supplements in Psychiatric Disorders Trends

Driving Forces: What's Propelling the Nutritional Supplements in Psychiatric Disorders Market?

Challenges and Restraints in Nutritional Supplements in Psychiatric Disorders

Key Region or Country & Segment to Dominate the Market

Growth Catalysts in Nutritional Supplements in Psychiatric Disorders Industry

Leading Players in the Nutritional Supplements in Psychiatric Disorders Market

Significant Developments in Nutritional Supplements in Psychiatric Disorders Sector

Comprehensive Coverage Nutritional Supplements in Psychiatric Disorders Report

Nutritional Supplements in Psychiatric Disorders Segmentation

Nutritional Supplements in Psychiatric Disorders Segmentation By Geography

Market Growth (million)

Market Growth (million)

Regional Market Share

Market Size (million)

Market Size (million)

Market Snapshot

Nutritional Supplements in Psychiatric Disorders Segmentation

Nutritional Supplements in Psychiatric Disorders Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the projected Compound Annual Growth Rate (CAGR) of the Nutritional Supplements in Psychiatric Disorders?

2. Which companies are prominent players in the Nutritional Supplements in Psychiatric Disorders?

3. What are the main segments of the Nutritional Supplements in Psychiatric Disorders?

4. Can you provide details about the market size?

5. What are some drivers contributing to market growth?

6. What are the notable trends driving market growth?

7. Are there any restraints impacting market growth?

8. Can you provide examples of recent developments in the market?

9. What pricing options are available for accessing the report?

10. Is the market size provided in terms of value or volume?

11. Are there any specific market keywords associated with the report?

12. How do I determine which pricing option suits my needs best?

13. Are there any additional resources or data provided in the Nutritional Supplements in Psychiatric Disorders report?

14. How can I stay updated on further developments or reports in the Nutritional Supplements in Psychiatric Disorders?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Key Insights

Nutritional Supplements in Psychiatric Disorders Trends

Driving Forces: What's Propelling the Nutritional Supplements in Psychiatric Disorders Market?

Challenges and Restraints in Nutritional Supplements in Psychiatric Disorders

Key Region or Country & Segment to Dominate the Market

Growth Catalysts in Nutritional Supplements in Psychiatric Disorders Industry

Leading Players in the Nutritional Supplements in Psychiatric Disorders Market

Significant Developments in Nutritional Supplements in Psychiatric Disorders Sector

Comprehensive Coverage Nutritional Supplements in Psychiatric Disorders Report

Nutritional Supplements in Psychiatric Disorders Segmentation

Nutritional Supplements in Psychiatric Disorders Segmentation By Geography

Market Growth (million)

Market Growth (million)

Regional Market Share

Market Size (million)

Market Size (million)

Market Snapshot

Nutritional Supplements in Psychiatric Disorders Segmentation

Nutritional Supplements in Psychiatric Disorders Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the projected Compound Annual Growth Rate (CAGR) of the Nutritional Supplements in Psychiatric Disorders?

2. Which companies are prominent players in the Nutritional Supplements in Psychiatric Disorders?

3. What are the main segments of the Nutritional Supplements in Psychiatric Disorders?

4. Can you provide details about the market size?

5. What are some drivers contributing to market growth?

6. What are the notable trends driving market growth?

7. Are there any restraints impacting market growth?

8. Can you provide examples of recent developments in the market?

9. What pricing options are available for accessing the report?

10. Is the market size provided in terms of value or volume?